Journal of Bioactive and Compatible Polymers · 1998 · 50 citations · 13 references
PharmacyPharmaceuticsPharmacologyControlled Release FormulationsDrug DeliveryPharmaceutical FormulationBiodegradable PolymersBiodegradationDegradation ProductsDrug Delivery BiomaterialsDrug Delivery SystemsPolymeric Drug Delivery SystemsBiodegradable Delivery MaterialsBiodegradable Delivery SystemsBiodegradable Drug CarriersBiodegradable Polymer MatricesControlled Burst ReleaseDegradationDegradation BehaviorDrug Delivery Polymers
We prepared poly(γ-glutamic acid)(γ-PGA) benzyl ester(γ-PBG) by the esterification of γ-PGA and benzyl bromide and evaluated the degradation behavior and its usefulness as a drug delivery system (DDS) matrix using 5-fluorouracil (5-FU) as a model drug. γ-PBG degraded in an acidic solution gradually for up to 130 days, and degraded very slowly in a phosphate buffer solution (pH 7.4). After 150 days, the weight loss of the γ-PBG film was only 10% in a phosphate buffer solution. A slow release of 5-FU from γ-PBG films was achieved. The release rate was affected by the pH of the outer solution and the loading drug. We observed an initial burst-release on the first day, after that, the release of 5-FU was diffusion-controlled. γ-PBG may be a novel biodegradable material that may be useful in the pharmaceutical, biomedical, and agricultural fields.
13
Drug Carriers in Biology and Medicine
Ian Shaw · Biochemical Society Transactions · 1980 · 289 citations